Vivos, Inc. (RDGL)
0.0453
0.00 (0.00%)
USD |
OTCM |
Oct 06, 16:00
Vivos EPS Diluted (Quarterly) : -0.0017 for June 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.0017 |
| March 31, 2026 | -0.0026 |
| December 31, 2025 | -0.0024 |
| September 30, 2025 | -0.0011 |
| June 30, 2025 | -0.0014 |
| March 31, 2025 | -0.0019 |
| December 31, 2024 | -0.0024 |
| September 30, 2024 | -0.002 |
| June 30, 2024 | -0.0012 |
| March 31, 2024 | -0.0014 |
| December 31, 2023 | -0.0029 |
| September 30, 2023 | -0.0018 |
| June 30, 2023 | -0.0024 |
| March 31, 2023 | -0.0007 |
| December 31, 2022 | -0.002 |
| September 30, 2022 | -0.0008 |
| June 30, 2022 | -0.0023 |
| March 31, 2022 | -0.002 |
| December 31, 2021 | -0.0005 |
| September 30, 2021 | -0.0006 |
| June 30, 2021 | -0.0057 |
| March 31, 2021 | -0.001 |
| December 31, 2020 | -0.0012 |
| September 30, 2020 | -0.0006 |
| June 30, 2020 | -0.0009 |
| Date | Value |
|---|---|
| March 31, 2020 | -0.0019 |
| December 31, 2019 | -0.0028 |
| September 30, 2019 | -0.0038 |
| June 30, 2019 | -0.0012 |
| March 31, 2019 | -0.0014 |
| December 31, 2018 | 0.1598 |
| September 30, 2018 | -0.5573 |
| June 30, 2018 | -0.5446 |
| March 31, 2018 | -0.1084 |
| December 31, 2017 | -0.3196 |
| September 30, 2017 | -0.2834 |
| June 30, 2017 | -0.2615 |
| March 31, 2017 | -0.0877 |
| December 31, 2016 | 0.073 |
| September 30, 2016 | -0.08 |
| June 30, 2016 | -1.68 |
| March 31, 2016 | -2.32 |
| December 31, 2015 | 0.248 |
| September 30, 2015 | -1.016 |
| June 30, 2015 | 2.72 |
| March 31, 2015 | 0.72 |
| December 31, 2014 | -7.00 |
| September 30, 2014 | -3.032 |
| June 30, 2014 | -8.00 |
| March 31, 2014 | -8.00 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| IDEXX Laboratories, Inc. | 4.267 |
| Neogen Corp. | -0.0519 |
| QuidelOrtho Corp. | -1.360 |
| Aspira Women's Health, Inc. | -0.0547 |
| Biomerica, Inc. | -0.3729 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -0.8302M |
| Revenue (Quarterly) | 0.0364M |
| Total Expenses (Quarterly) | 0.8666M |
| Enterprise Value | 29.49M |
| Gross Profit Margin (Quarterly) | -444.0% |
| Profit Margin (Quarterly) | -2.28K% |
| Earnings Yield | -17.23% |
| Normalized Earnings Yield | -14.36 |